Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours

Fig. 4

“Comet Assay” analysis in breast cancer patients. The DNA analysis has been performed ex vivo using circulating leukocytes of a. control group versus b. breast cancer patients. Apoptotic rates (class VI) have been correlated with decades of life in the pools of comparison. It is evident that the apoptotic rates normally tend to increase in the 5th and 6th decade of life. In contrast, the breast cancer patients demonstrate much more heterogeneous image and general tendency to decrease after the 3rd life decade. These results have been published earlier [25]

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us